AdvaMed 2010 has announced its conference keynote speakers. The meeting will take place on October 18–20 in Washington, DC. The speakers, announced today include: CMS Administrator  Donald Berwick; CBS Evening News Anchor Katie Couric; FDA Commissioner  Margaret Hamburg; and Secretary of Commerce Gary Locke
In addition, the conference will host a CEO's Unplugged segment, featuring "industry thought-leaders [who] will tackle everything from ethics and compliance to supply chain and legislative policy issues."  CEOs from companies such as Biomet, Medtronic, Edwards Lifesciences, and Abiomed (to name just a few) will be on hand to

September 28th, 2010

An FDA panel on Monday recommended Hologic's Selenia Digital Breast Tomosynthesis System for approval, but the device company's stock fell on the news, according to a report on The company's three-dimensional mammography system apparently still needs to prove itself.

"It's exciting, but it's a bit longer term," Bill Bonello of RBC Capital Markets told Forbes. In the article, the RBC Bonello pointed to a possible contingent of investors concerned about the short-term dynamics of the medical devices sector. "There has been continued weakness in office traffic, continuing expanding intervals with pap smears, and other things that would have investors worried," Bonello says.

September 27th, 2010

Nerac, a global research and advisory firm, has relased a report, "Fusion Trends & Opportunities—Medical Devices and Communications." It examines the concept of "technology fusion" between medical devices and telecommunications. Written by Nerac Analysts Tim Smith and Roz Sweeney, PhD, the 19-page report uses the term technology fusion to describe the innovative combination of differing technologies to produce new inventions. The report explores how the the medical device industry has recently seen technology fusion in two important areas:
•    Medical devices and communications.
•    Medical devices and energy harvesting.

The report examines the dynamics and opportunities associated with the fusion of medical device and communications technologies. It begins with a review of the trends within the fusing technology areas that are enabling remote patient monitoring (RPM) and then moves...

September 27th, 2010

In a 12-0 vote, an FDA panel has found Hologic's 3-D mammmography device to be safe. The panel stated that the Selenia Dimensions 3-D improves the detection of breast cancer when used with conventional 2-D mammography systems. The combination of 2-D mammography with Hologic's digital mammography tomosynthesis system could reduce recall rates and improve cancer detection. "The system is designed to increase accuracy when screening women for the presence of cancerous tissue, and to enable a more precise characterization of suspicious lesions," says Jay A. Stein, cofounder and chief technical officer of Hologic. "I speak for all of Hologic in voicing great satisfaction that the FDA panel has weighed in so positively in favor of this valuable new tool in the battle to limit breast cancer mortality."

Selenia Dimensions is currently approved in countries in...

September 27th, 2010

Royal DSM N.V. and DuPont have announced an agreement to form a joint venture to develop, manufacture, and commercialize advanced surgical biomedical materials. The agreement is pending European Union regulatory approval. The joint venture will be named Actamax Surgical Materials LLC. Under the joint venture agreement, DSM and DuPont will each share a 50% interest.
The joint venture, set to develop next-generation materials, will address the market for surgical sealants, adhesion barriers, and tissue adhesives. According to the companies, this is a large and underserved market of more than 100 million annual surgical procedures worldwide.
Actamax Surgical Materials LLC will build a comprehensive biomedical product portfolio based on several patent-protected biodegradable hydrogel technologies. The early technology development was completed utilizing DuPont materials science and biotechnology capabilities. Commercialization will rely on the...

September 23rd, 2010

IVD Technology, the only trade media brand designed exclusively for manufacturers of in vitro diagnostic products, is launching its first annual Virtual Conference and Tradeshow to be held on September 28, 2010. The Virtual Conference and Tradeshow will give in vitro diagnostic OEMs multimedia, real-time access to leading suppliers and event speakers from anywhere in the world, without the stress and cost of travel.

As the only media provider dedicated exclusively to the in vitro diagnostics market, IVD Technology has the unique opportunity to be a bellwether for the market. Stephen Corrick, VP of Medical Device Media, said, “As leaders in the in vitro diagnostics space, our goal is to address the needs of this important audience across all relevant media channels. We had previously discussed an event of this nature as a someday project, but when our research showed that over 70% of...

September 22nd, 2010

The medical device industry in Canada has reached $7.1-billion dollars. Medical Canada, Canada’s first-ever event to focus solely on medical devices, has been launched to give Canadian medical and dental device manufacturers a more efficient way to connect with the suppliers they rely on for innovation, quality improvements, and speed to market.
WHAT: Manufacturing Innovations – Medical Canada
WHEN: Wednesday, November 3 – Thursday, November 4
WHERE: International Center, Mississauga, Ontario

September 21st, 2010

Nearly 171 people die each day from catheter-related bloodstream infections (CRBSIs) in the United States. According to the CDC, it costs between $34,500 and $56,000 on average to treat these infections. In an effort to eliminate potentially 250,000 CRBSI fatalities, Cook Medical has expanded its line of antiobiotic-impregnated peripherally-inserted central venous catheters (PICCs). According to a study published in the New England Journal of Medicine, Cook's Spectrum  Turbo-Ject technology establishes zones of inhibition greater than up to 15 mm for up to 70 days against the leading cause of CRBSIs. The catheters provide broad spectrum protection against gram-positive and gram-negative organisms. Research has also shown that the Spectrum catheters don't promote the growth of antiobiotic-resistant strains of bacteria in patients with the catheters. 

Cook's full line of Spectrum catheters will...

September 20th, 2010

There's nothing like winning, especially when lots of hard work has been put into the endeavor. In the medical device world, one of the most prestigious accolades is the Medical Design Excellence Awards. Time has come around again for entries. See the release below for details.
Canon Communications’ 2011 Medical Design Excellence Awards Calls for Entries
Innovative products invited to participate in 14th annual competition
Los Angeles, CA, September 14, 2010 - The Medical Design Excellence Awards (MDEA) program is accepting entries for its 2011 competition from companies and individuals worldwide involved in the design, engineering, manufacture, or distribution of finished medical devices or packaging products.  The program is presented by Canon Communications, the leading producer of face-to-face, digital, print, and online business acceleration products for the worldwide medical device industry...

September 15th, 2010

The New York Times interviews manufacturers and prototypers that use 3-D printing. The video below focuses on how the price for 3-D print machines and the materials they use are dropping in price, and how the technology is enabling teh creation of custom medical devices. An evaluation of prototyping technologies used in medical device design, including a 3-D printing machine can be found here.




September 14th, 2010